GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Fuss Brands Corp (OTCPK:FBDS) » Definitions » Research & Development

Fuss Brands (Fuss Brands) Research & Development : $0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Fuss Brands Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Fuss Brands's Research & Development for the three months ended in Jan. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00 Mil.

Fuss Brands Research & Development Historical Data

The historical data trend for Fuss Brands's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuss Brands Research & Development Chart

Fuss Brands Annual Data
Trend Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct20 Oct21 Oct22 Oct23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fuss Brands Quarterly Data
Apr13 Jul13 Oct13 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fuss Brands Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuss Brands  (OTCPK:FBDS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fuss Brands Research & Development Related Terms

Thank you for viewing the detailed overview of Fuss Brands's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Fuss Brands (Fuss Brands) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Fuss Brands Corp (OTCPK:FBDS) » Definitions » Research & Development
Comparable Companies
KAST CLOW GMZP AMLH EEGI MTLK MDWK BDCC USCTD ZHUD BOM:543385 PBAJ CVII AACT LSE:ADMR ANSC NETD WFHG SCRM RRAC
Traded in Other Exchanges
N/A
Address
80 Broad Street, New York, NY, USA, 10004
Website
https://www.fussbrands.com
Fuss Brands Corp is a shell company.
Executives
Lei Zhao director LEVEL 11, CHANGLIANG INTERNATIONAL BLDG, NO. 28, CHANGLIANG RD, NANGANG DISTRICT, HEILONGJIAN PROVINCE F4 150090
Zibing Pan director 1813 NW 176TH PL., EDMOND OK 73012
David Dong officer: Chief Financial Officer C/O FEIHE INTERNATIONAL, INC., 2275 HUNTINGTON DRIVE #278, SAN MARINO CA 91108
Xiaoying Lu officer: Interim CFO C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN,HEILONGJIANG PROVINCE F4 150050
Dianjun Pi director 281 TAIPING ROAD, DAOWAI DISTRICT, HARBIN, HEILONGJIANG F4 150300
Changxiong Sun director C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Bingchun Wu director C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Sean Shao director 21ST FLOOR, EVERBRIGHT BANK BUILDING, ZHUZILIN, FUTIAN DISTRICT, SHENZHEN, GUANGDONG F4 518040
Yan Yi Chen officer: Chief Financial Officer NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Magnus Moliteus director 958 SUNSET RIDGE, BRIDGEWATER NJ 08807
Yanfei Kong director, officer: CFO 65 BROADWAY, SUITE 888, NEW YORK NY 10006
Li Shaoming director, 10 percent owner, officer: Chairman and CEO 281 TAIPING ROAD, DAOWAI DISTRICT, HARBIN, HEILONGJIAN F4 150300
Fanrong Meng director 201-5-602 YUNHUA SQUARE, KANGAN ROAD, HARBIN, HEILONGJIAN F4 150010
Kenneth Arevalo director 3200 BRISTOL STREET, SUITE 700, COSTA MESA CA 92626
Sutter Holding Co Inc 10 percent owner 100 SOUTH KING STREET, SEATTLE WA 98104

Fuss Brands (Fuss Brands) Headlines

No Headlines